Maximilian Von Poelnitz
Managing Director at Ajinomoto Corporate Venture Capital
Maximilian Von Poelnitz
Managing Director at Ajinomoto Corporate Venture Capital
San Francisco Bay Area
Overview
Work Experience
Managing Director
2023 - Current
I lead our energy , climate, and food tech investing. Ajinomoto CVC is the corporate venture capital arm of Ajinomoto, a $10B revenue technology leader in amino science. We invest in transformative companies that advance new ways to extend health span, develop new approaches that change the ways information is processed, and answer complex challenges in sustainability. Together with Ajinomoto’s community of scientists and engineers, we enable startup founders to build and scale solutions for the future. Contact me or message me for further info on our focus in semiconductor packaging, battery innovation, medical nutrition, and green food tech
Investor
2024
Investor
2021
Investor
2019
Investor
2020
Executive Advisor
2023 - 2024
EQUII's irresistibly delicious complete protein products are the perfect match between healthy and hearty. The company is founded by accomplished food scientists Monica Bhatia, Ph.D., and Baljit Ghotra Ph.D., along with world-class chef Sebastien Canonne, M.O.F. I'm working with them on their Series A and their US expansion plans.
Executive Advisor
2023 - 2024
Corporate development and strategy work. I help the executive team in regard to corporate development, go-to-market strategic planning, and sales pipeline activities.
Venture Partner
2019 - 2023
Loyal is a global venture fund designed to offer above-average returns, exceptional capital preservation and quarterly liquidity, through a unique gate-stage process that reduces bias. Partnered with INSEAD, Founder Institute, 900+ advisors, and 200+ investors, we are Loyal to the world with 300+ investments in 60+ countries.
Board Member
2022 - 2023
Investment Director, DSM Venturing
2021 - 2022
As an Investment Director, responsible for US Dealflow and representing the fund in both bio tech, food tech, and nutrition investing. Structured and led multiple investments including Rootine, Cybele, and Aavia. Sat on multiple boards and researched our early-stage incubator partnership options. DSM Venturing, the corporate venture arm of DSM, is active in various domains: Human and Animal Nutrition, Industrial Biotech, Biomedical, and Alternative.